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ABSTRACT A three-chained peptide from type I collagen,
crosslinked by hydroxyaldolhistidine, has been isolated from a
tryptic digest of5 M guanidine HCI-insoluble bovine skin collagen
(a small but as yet unknown percentage of the total collagen in
whole skin). Os04/NaIO4 specifically cleaved the crosslink at its
double bond into a two-chained crosslink peptide and a single pep-
tide. The sequence of the two-chained peptide containing the bi-
functional crosslink was determined after amino acid analysis of
the separated peptides. The crosslink consists of an aldehyde de-
rived from hydroxylysine-87 in the aldehyde-containing cyanogen
bromide fragment alCB5ald and an aldehyde derived from the
lysine in the COOH-terminal nonhelical region of the alCB6ald
fragment. The alCB6ald portion of the peptide exhibited struc-
tural microheterogeneity, containing the inverted sequence Ala-
Lys-His instead of the normal sequence Lys-Ala-His. This indi-
cates that another structural gene exists for al(I) chain. The orig-
inal three-chained peptide did not contain any glycosylated hy-
droxylysine or glycosylated hydroxyaldolhistidine. The lack of
glycosylation of hydroxylysine-87 in alCB5, which is usually gly-
cosylated, allowed formation of the aldehyde, and this, coupled
with the sequence inversion, may have allowed formation of the
nonreducible crosslink hydroxyaldolhistidine. We suggest that the
role of glycosylation, a posttranslational modification, of specific
hydroxylysine residues is to prevent their oxidative deamination
to aldehydes, thereby precluding formation of complex stable
crosslinks. Complex crosslinks would decrease the rate of collagen
turnover. The decrease, with time, would increase the population
of stable crosslinked collagen molecules, which would eventually
accumulate with age.
The crosslinking and maturation of collagen is initiated by the
action of lysyl oxidase on fibrils. The enzyme converts the 6-
carbon atoms of specific peptidyl lysine and hydroxylysine
moieties to aldehydes by enzymic oxidative deamination (1, 2).
In the first stages, aldehydes can either self-condense to form
aldol condensation product (aldol, an a,f3-unsaturated alde-
hyde, the intramolecular crosslink) or condense with s-NH2
groups of other specific peptidyl lysine and hydroxylysine res-
idues to form imminium intermolecular crosslinks (3, 4). Re-
cently Fukae and Mechanic (5) have demonstrated that the ini-
tial step in the temporal sequence is conversion of the lysine
residue at position 17C in the al(I) chain to a-aminoadipoyl-&
semialdehyde, and this aldehyde forms imminium intermolec-
ular crosslinks before aldol'intramolecular crosslinks.
Histidinedis an amino acid that is very sparse in collagen (14
of.a total of approximately 3,150 amino acids), yet it is a con-
stituent of the relatively abundant NaBH4-reduced imminium
crosslink; histidinohydroxymerodesmosine .(HisOHMerDes)
(6,7). Recently it has been clearly demonstrated by Bernstein
and Mechanic (8) that dehydro-HisOHMerDes, which was
thought to be artifactual (9, 10) is a true crosslink in collagen
fibrils. Bernstein and Mechanic found that one HisOHMerDes
crosslink was present per molecule of collagen in freshly re-
constituted soluble collagen fibrils.
Histidine was also found to be a constituent of the stable
nonreducible trifunctional crosslink hydroxyaldolhistidine
(OHAlHis), whose structure was elucidated by PMR and mass
spectrometry (11). OHAIHis was isolated from bovine skin col-
lagen. Becker et aL (12) isolated a three-chained crosslinked
peptide from a tryptic digest of insoluble bovine skin; it con-
tained three NH2- and three COOH-terminal residues. Hous-
ley et al (11) demonstrated that the crosslink in the peptide
isolated by Becker et al. (12) corresponded to OHAlHis.
Serological studies, end-group analysis, and CNBr cleavage
indicated that the three-chained crosslinked peptide contained
a portion ofthe COOH-terminal nonhelical peptide of cleavage
fragment a1CB6 and a portion offragment alCB5 as two ofthe
three chains of the peptide (12). However, assignments of the
location of the contributing amino acid residues or the involve-
ment of their prosthetic groups were not made.
The functional role of the sugar residues linked to hydroxy-
lysine in collagen is not clearly known. However, it has been
suggested that they may be involved in directing molecular as-
sembly because their locations in the molecule would place
them in the "hole" regions [0.6D spaces of fibril (D = 670 A)]
(13, 14). It has also been suggested that if glycosylation of E-
amino groups occurred, it could be a form by which the avail-
ability of such groups could be regulated for crosslink formation
(15). The role of sugar in collagen in this type ofmechanism and
the former functional hypothesis still await confirmation. It has
also been suggested that glycosylation of hydroxylysine directs
the formation of some crosslinks (16). This hypothesis also still
requires verification.
In order to understand the specific structure-function rela-
tionships of collagen matrices in different tissues, and to elu-
cidate the fibrillar three-dimensional packing of collagen mol-
ecules, itis necessary to identify the molecular loci ofthe various
intermolecular crosslinks.
The. postulated structure for OHAlHis contains a doubly
bonded carbon atom that is linked to the Nr of the imidazole
ring of histidine (11). Previouslywe have used osmium tetroxide
to convert a double bond into a vic-diol in the unequivocal syn-
thesis of dihydroxynorleucine (17). In order to determine the
location ofOHAIHis, we isolated the crosslinked peptide by the
method of Becker et aL (12) and converted the double bond to
a vic-diol and specifically cleaved the three-chained peptide
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with metaperiodate into a double-chained peptide and a single
peptide.
MATERIALS AND METHODS
Peptide fraction 5, the fraction containing the three-chained
peptide linked by OHAlHis, was prepared as described (12)
from 78.8 g of the same batch of insoluble bovine skin collagen
from which OHAlHis was isolated previously (11).
Amino Acid Analyses. Samples were hydrolyzed for 24 hr at
1100C in vacuo with 3 M p-toluenesulfonic acid in glass test
tubes or with 2 M NaOH in polypropylene tubes enclosed in
an evacuated glass test tube. Analyses were performed in du-
plicate on an LKB model 4400 HPLC amino acid analyzer.
Chromatographic Procedures. See legends of Figs. 1, 2, and
3 for details. Columns of Bio-Gel P-2 were used for desalting.
Amino Acid Sequence Analysis. A Beckman 890 C sequencer
using an 0.1 M Quadrol program and 3 mg of Polybrene (18)
was utilized. The phenylthiohydantoin derivatives of amino
acids were identified by reverse-phase chromatography using
a Beckman/Altex 324 HPLC unit with an Ultrasphere octa-
decylsilyl (ODS) column (4.6 x 250 mm). Gradient elution was
carried out at 550C; the aqueous mobile phase component was
0.01 M sodium acetate (pH 4.9), and the organic component was
acetonitrile.
Chemical Procedures. The isolated three-chained crosslink
peptide (5 mg) was completely derivatized by using a 10-fold
molar excess of di-tert-butylcarbonate (calculated on the basis
of 10 possible derivatizable nitrogen groups) according to the
method described in ref. 19. The blocked peptide was desalted
by using a column of Bio-Gel P-2.
The crosslink peptide was cleaved specifically at the double
bond in OHAIHis by the use of Os04/NaIO4 by the method
of Reinecke et aL (20). The peptides were deblocked after cleav-
age, for sequence analysis, by using HCl in formic acid by a
described method (21).
RESULTS
Peptide fraction 5 (12) was rechromatographed on phosphocel-
lulose with a concave gradient and was found to be heteroge-
neous (Fig. 1).
The fraction denoted by the bar in Fig. 1 was chromato-
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FIG. 2. Chromatography of the pooled peak from Fig. 1 on a
DEAE-cellulose column (2.5 x 8 cm)jacketed at 420C and equilibrated
with 0.01 M Tris HCl (pH 8.2) as the starting buffer. After application
of the sample, the column was eluted with 260 ml of starting buffer
and 240 ml of a linear gradient generated by two equal chambers. The
first contained 200 ml of starting buffer and the second contained 200
ml of starting buffer and 0.2M NaCl. The column was then eluted with
100 ml of starting buffer containing 0.5 M NaCl (arrow). Flow rate was
150 ml/hr; 5-ml fractions were collected. The fractions thatwere pooled
for further work are represented by the bars under the three peaks IV,
V, and VI. The fractions in each peak were pooled separately.
2. Only the peaks denoted IV, V, and VI contained OHAlHis.
Peak VI was rechromatographed on Sephadex G-50, and it
eluted as a single symmetrical peak corresponding to the po-
sition of peak I in Fig. 3. The amino acid composition of peak
VI (Fig. 2) is shown in Table 1. Peaks IV and V of Fig. 2 had
extremely similar compositions. No calculation is presented for
OHAlHis, which eluted 6.2 min after phenylalanine and 4.3 min
before hydroxylysine. It possessed 3.1 times the color factor of
leucine in our system. It eluted at a different position from that
of an authentic sample of the pyridinoline crosslink obtained
from David Eyre. The composition of the peptide differed
somewhat from that previously reported by Becker et al. (12)
(column 5, Table 1).
Amino acid analysis after alkaline hydrolysis of the peptide
indicated that hydroxylysine and OHAlHis were not glycosyl-
ated, because their elution positions were unchanged.
Derivatization of the crosslink peptide with t-Boc was com-
plete, because there was no retardation of the peptide when a
solution of the peptide in 0.001 M lithium formate at pH 3.8
was applied to the phosphocellulose column. This was con-
firmed by amino acid analysis after metaperiodate (see below)
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FIG. 1. Rechromatography of peptide fraction 5 (ref. 12) on a phos-
phocellulose column (1.5 x 24 cm) jacketed at 42°0 and equilibrated
with 0.001 M lithium formate buffer, pH 3.8, containing 0.5% 2-pro-
panol. After application of the sample in equilibration buffer, the col-
umn was eluted with a simple concave gradient generated by a three-
chambered Varigrad (Mark Instrument, Villanova, PA) containing 180
ml of 0.001 M lithium formate, pH 3.8/0.5% 2-propanol in the first two
chambers and 180 ml of 0.001 M lithium formate, pH 3.8/0.5% 2-pro-
panol/0.3 M LiCl in the third chamber. Flow rate was 150 ml/hr; 5-
ml fractions were collected. The bar under the peak denotes the frac-
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FIG. 3. Chromatography of peak VI from Fig. 2 after complete de-
rivatization with t-butoxycarbonyl (t-Boc) and reaction with 0s04/
NaIO4 on a Sephadex G-50 superfine column (1.8 x 230 cm) equili-
brated with 2M guanidine-HCl buffered with 0.05MTris HCl (pH 7.5).
Flow rate was 25 ml/hr; 5-ml fractions were collected. The fractions
under each peak denoted by the bars were pooled.
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Table 1. Amino acid compositions
+ Peptide
Residue VI* IPt mt m 5S
Hyp 8 (8.1) 6 (5.8) 2 (1.8) 8 10
Asp 8 (8.2) 6 (5.6) 2 (1.8) 8 6
Thr§ 4 (3.9) 3 (2.6) 1(1.1) 4 4
Ser§ 2 (1.9) 1 (1.1) 1 (1.0) 2 3
Glu 9 (9.2) 6 (6.2) 4 (3.8) 10 8
Pro 8 (7.9) 5 (5.3) 3 (3.2) 8 13
Gly 27 (27.4) 18 (18.3) 7 (7.4) 25 31
Ala 8 (7.5) 5 (4.9) 2 (2.1) 7 8
Val 1 (1.4) 1 (1.0) - 1 1
Mets 1 (0.8) 0 (0.3) 1 (1.0) 1 1
ile 1 (0.7) 0 (0.4) - 1
Leu 8 (7.7) 5 (5.1) 4 (3.7) 9 7
Tyr 0 (0.3) 0 (0.3) - - 1
Phe 2 (1.6) 1 (0.8) 1 (1.0) 2 2
Hyl 3 (3.3) 3 (2.8) - 3 2
His 2 (1.7) 1 (1.0) 2 (1.8) 3 2
Lys 0 (0.4) 0 (0.2) - - -
Arg 4 (4.0) 2 (2.4) 2 (2.3) 4 4
Total 96 63 32 95 104
Values are expressed as the integral number of residues per peptide,
with experimental values in parentheses. Unreported values indicate
less than 0.2 residue found.
* Fig. 2.
t Fig. 3.
t Composition from ref. 12.
§ Uncorrected for destruction on hydrolysis.
I Methionine and methionine sulfoxide.
stroyed. Fig. 4 represents the series of reactions used to spe-
cifically cleave the t-Boc-derivatized three-chained peptide.
Amino acid analyses indicated quantitative conversion of com-
pound I (Fig. 4) to compound II. OHAIHis had completely dis-
appeared from the chromatogram. After metaperiodate cleav-
age (Fig. 4) the reaction mixture was filtered on the Sephadex
G-50 superfine column (Fig. 3). Peak II was refiltered and was
separated from the small amount of contaminating peak I pep-
tide. Amino acid analyses ofpeaks II and III are shown in Table
1. Note that the histidine in column II + III represents the
predicted amount after metaperiodate cleavage of compound
II (Fig. 4). Incomplete cleavage of the peptide was obtained
(Fig. 3). It is probable that the reaction conditions (time, tem-
perature, and pH) were not optimal for more complete cleav-
age. Conditions must be sought to attain quantitative splitting
of the crosslink.
The summary of the sequence data for peak III (Fig. 3) is
presented in Table 2 and Fig. 5. The data indicates a two-
chained crosslinked peptide. No peak representing any phen-
ylthiohydantoin derivative was observed in the organic layer of
cycle 14. These results indicated that the hydroxylysine at res-
idue 87 and the lysine in the COOH-terminal nonhelical pep-
tide of al(I) were involved in the crosslink in the two-chain
peptide sequenced.
Our data suggest that an inversion in the sequence occurs at
residue 17, which corresponds to sequence cycle 13 (Table 2),
at which one residue of alanine is clearly identified. In cycle 14,
the crosslinked lysine residue is not seen, but it is cleaved be-
cause we find a residue of histidine in cycle 15. It must be em-
phasized that equal amounts of histidine phenylthiohydantoin
were recovered in cycles 14 and 15. The same sequence results
were obtained five times with the same and other preparations
of peak III (Fig. 3).
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FIG. 4. Specific cleavage of OHAlHis three-chained peptide. The
completely t-Boc-derivatized peptide (I) reacted with 0804 to yield the
vic-diol (II). The vic-diol reacted with NaIO4 to yield the (3-hydroxy-
ketone crosslinked two-chained peptide (III) and the single peptide
containing the formaldehyde adduct of histidine (IV). Elimination of
H20 from the unstable &3-hydroxyketone to yield the cor ugated a,,-
unsaturated ketone (V) occurs in the same manner as aldol conden-
sation in collagen, to yield the a,4-unsaturated aldehyde intramolecu-
lar crosslink. Loss of formaldehyde from histidine to give VI is anal-
ogous to metaperiodate cleavage of hydroxylysinonorleucine to yield
lysine (see ref. 22).
as the complete three-chained peptide to arrive at the identity
of the third chain, which contributes its histidine to OHAlHis,
were unsuccessful; the sequence results of the complete three-
chained peptide yielded only the expected two sequences seen
with peak III. This was believed due to a blocked NH2-terminal
residue on this third chain. It is necessary to prepare more
material so that it will be possible to enzymically cleave the
isolated third chain, separate the pieces, and determine their
sequences to arrive at its structure.
DISCUSSION
Our laboratory has been interested in the structure-function
relationships of collagenous tissues containing type I collagen.
Although all type I collagen matrices have the same packing
arrangements and identical amino acid sequences (24, 25), re-
cent data have indicated that differences in the molecular dis-
tribution of the same intermolecular crosslinks might explain
the varied physiological functions these tissues display. In order
to relate crosslink distribution with structure and function of
collagen matrices it is necessary to demonstrate the molecular
loci of those prosthetic groups that contribute to the formation
of the crosslinks.
It has been suggested that the crosslink OHAlHis forms by
condensation, by an as yet unknown mechanism, from one res-
idue each of peptidyl 8-hydroxy-a-aminoadipoyl-8-semialde-
hyde, a-aminoadipoyl-8-semialdehyde, and histidine, with the
Proc. Nad Acad. Sci. USA 79 (1982)
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Table 2. Amino acid sequence and composition of peak III (Fig.




se- compo- Differ- +
Cycle* Residue quence sitiont encet 5c-23c§
3, 9 Hyp 2 2 (1.8) 0 2
1 Asp 1 2(1.8) 1 2
5 Thr 1 1(1.1)0 0 1
3 Ser 1 1(1.0) 0 1
7,10 Gln 2
Glx 4 (3.8)
11,12 Glu 2 0 2
6,8,9 Pro 3 3(3.2) 0 3
1,4,7,10,13 Gly 5 7 (7.4) 2 7
6,13 Ala 2 2 (2.1) 0 2
11 Met 1 1 (1.0)11 0 1
2,5,8 Leu 4 4(3.7) 0 4
4 Phe 1 1(1.0) 0 1
14,15 His 2 2(1.8) 0 2
15 Arg 1 2(2.3) 1 2
Lys - - 1
12, 14 X** 2
Hyl (0.2) - 1
Total 30 32 4 34
* Only 15 cycles on the sequenator were completed. The HPLC chro-
matogram exhibited single peaks in cycles 12 and 14 that corre-
sponded to one residue of glutamic acid and histidine in each cycle,
respectively. Cycle 2 exhibited one peak, which corresponded to two
residues of leucine.
t Amino acid analysis indicated only 32 residues. A residue each of
lysine and hydroxylysine, which are coupled in a crosslink, bring the
total to 34, equal to the theoretical amount from the literature. Val-
ues are residues per peptide, experimental values in parentheses.
Unreported values indicates less than 0.2 residue found.
t The difference of four residues corresponds to positions 20C to 23c of
the COOH-terminal nonhelical peptide of the al(I) chain, which has
the sequence of Asp-Gly-Gly-Arg.
§ Data from ref 23.
¶ Uncorrected for destruction on hydrolysis.
II Methionine and methionine sulfoxide.
** From sequence considerations the crosslink in this two-chain pep-
tide consists of a residue of hydroxylysine linked to a residue of
lysine.
latter contributing the NT of the imidazole ring (11).
The proposed structure containing an ethylene group on the
NT ofHis (I in Fig. 4) allowed one ofus (G. L. M.) to propose from
previous experiences (17) a series of reactions that would spe-
cifically cleave the crosslink into two moieties (Fig. 4). We
aICB4 IN IXICB5-
76 8o 90 o RESIDUE NUMBER
*Gly*Leu-Hyp-Gly Thr*Ala*Gly-Leu*Hyp Gly-Met*Hyl*Gly*His*Arg-
2 3 4 5 6 7 8 9 10 11 1213 14 15 -4 SEQUENCE STEP
5e ,d 19\, RESIDUE NUMBER
*Asp*Leu Ser Phe-Leu*Pro* GInPro Pro Gln GiuGu Ala Lys- His-
2 3 4 5 6 7 8 9 10 11 12 13 14 15 4SEQUENCE STEP
a ICB6
FIG. 5. Sequence of two-chained crosslinked peptide obtained by
specific cleavage of three-chained OHAlHis crosslink peptide. The res-
idue numbers in the collagen sequence are above the amino acid res-
idues. The half-headed arrows with the numbers of the sequence step
below are results obtained from the sequenator. The arrows denote that
the residue was identified in the sequence step assigned. See Table 2
for other details.
therefore prepared peptide 5, the three-chained peptide con-
taining OHAlHis, by the methods described previously (12).
We further purified this heterogeneous fraction (Fig. 2) and
found three peaks (IV, V, and VI) that contained OHAIHis, with
each peak possessing very similar amino acid compositions (typ-
ical example, peak VI in Table 1). Chromatographic separation
of the three on the DEAE-cellulose column could possibly be
due to variances in amidation of COOH groups.
The amino acid compositions and the sequence results ob-
tained after cleavage seemed to confirm the proposed structure
of OHAlHis (11).
Sequence analyses and amino acid composition of peak III
(Fig. 3) unequivocally demonstrated that it was a two-chained
crosslink peptide (Table 2 and Fig. 5). The residues that par-
ticipate in the crosslink are Hyl-87 (in alCB5 Ild; ald indicating
the aldehyde form) and the lysine residue in the COOH-ter-
minal nonhelical peptide portion of alCB6ald. The amino acid
composition and sequence indicate that the portion of alCB6a"d
isolated as part of the two-chained peptide described in this
report consists of 19 residues starting with Asp-5c and ending
with Arg-23C. In the earlier work describing the sequence ofthe
COOH-terminal portion of al(I), a 44-residue peptide isolated
from a tryptic digest ofthe al(I) chain of bovine collagen started
with Thr-993 and terminated with Arg-23c (26, 27). The peptide
isolated in this report undoubtedly resulted from a chymotryp-
tic cleavage that occurred between Tyr4c and Asp-5'. It is
known that even tosylamido-2-phenylethyl chloromethyl ke-
tone-treated trypsin, which was used to digest the collagen,
contains significant chymotryptic activity (28). The other branch
ofthe crosslinked two-chained peptide, which started with Gly-
76 and terminated with Arg-90, resulted from a typical tryptic
cleavage at Arg-75 and Arg-90.
In this paper we report apparent structural microhetero-
geneity surrounding the crosslinking moiety (a-aminoadipoyl-
8-semialdehyde) in the COOH-terminal nonhelical region of
alCB6ald. Starting with 15C and ending at 19c, the previously
published sequence (23, 26, 27) is Glx-Glx-Lys(ald)-Ala-His,
whereas we have found the sequence in the crosslinked peptide
for the same residue numbers to be Glu-Glu-Ala-Lys(ald)-His.
The evidence for this sequence inversion relies on the finding
that one residue of glycine and one residue of alanine were re-
covered in cycle 13 and one residue of histidine and no residue
for the crosslinked lysine was detected in cycle 14, a finding that
departs from the previously published sequence Lys-Ala-His.
In order for this sequence of recoveries to occur for the se-
quence Lys-Ala-His, a completely unknown chemical reaction
would have to be proposed whereby the modified lysine-de-
rived crosslinking residue cleaves from the alanine in the se-
quencing cycle before it is supposed to be degraded. The latter
is highly unlikely because our data from multiple sequencer
runs demonstrate alanine in good yield on cycle 13. For its true
location to be cycle 14, the previous residue (crosslinked lysine)
would have to undergo complete cleavage during the coupling
step (basic pH). For example, histidine, which has a tendency
to undergo premature cleavage, does so only to the extent of
10% in our sequencing system when it does occur. However,
because we found equal amounts of histidine in cycles 14 and
15 we can presume that no premature cleavage is occurring. In
addition, the other chain containing the other member of the
crosslink has the sequence Hyl-Gly-His. This cleaved normally
and reads as the normal sequence for a1CB5. It is these facts
that permit us to propose the sequence microheterogeneity
found in alCB6.
The molar amount of three-chained peptide in the insoluble
bovine skin collagen represents a small percentage of the total
amount of the three same peptides uncrosslinked in the type
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I collagen present in bovine skin. Recently the sequence of the
bases in a portion of the more abundant cDNA that codes for
al(I) in chicken collagen has been determined (29). The peptide
sequence represented by the base triplets for the same peptide
residues as above are Glu-Glu-Lys-Ala-His, the sequence re-
ported in the literature that was described above. It therefore
seems likely that there may exist small amounts ofanother struc-
tural gene that codes for an al(I) whose expression is the altered
sequence found here. The newly found sequence Ala-Lys, cou-
pled to the formation of 8-hydroxy-a-aminoadipoyl-8-semialde-
hyde from Hyl-87, allows for the "anomalous" production ofthe
complex nonreducible stable crosslink OHAIHis in bovine skin
collagen. It is well known that, the more crosslinked a collagen
is, the less susceptible it is to enzymic digestion. With age
OHAlHis crosslinked collagen may build up in a collagenous
tissue because its degradation rate is slower.
Another odd fact concerns the residue 8-hydroxy-a-amino-
adipoyl-8-semialdehyde (derived from Hyl-87), whose pros-
thetic group is part of the crosslink. It has been reported that
Hyl-87 in a1CB5 is about 80% glycosylated in rat skin (30)
whereas it is only 60% glycosylated in bovine skin collagen (15).
We believe that glycosylation of hydroxylysine prevents it from
forming in aldehyde. This is substantiated by the fact that gly-
cosylated dihydroxynorleucine has never been found in any
NaB3H4-reduced collagen in any genetic type (unpublished
data), whereas nonglycosylated dihydroxynorleucine is abun-
dant in reduced collagens (17, 31). Glycosylated Hyl-87 in
a1CB5 has been found in crosslinked peptide form with Lys-17c
in a1CB6ald previously as glycosylated dihydroxylysinonorleu-
cine and hydroxylysinonorleucine (16, 32-34). It is remarkable
that the small portion of nonglycosylated hydroxylysine at res-
idue 87 in bovine skin collagen forms an aldehyde and, coupled
with the sequence inversion, allows the formation of the cross-
link OHAlHis. This suggests that the role of glycosylation of
certain specific hydroxylysine residues in collagen is to ensure
the formation of simple bimolecular crosslinks and prevent the
formation of 6-hydroxy-a-aminoadipoyl-8-semialdehyde in or-
der to control complex stable crosslink formation. The lack of
complete glycosylation of Hyl-87 and the presence of a small
amount ofanother al(I) structural gene that codes the sequence
inversion in collagen are possibly biologic errors of evolution.
Recently it has been demonstrated that the COOH-terminal
nonhelical portion ofthe collagen molecule contains the Lys-17c
that is converted to a residue of a-aminoadipoyl-8-semialde-
hyde before any NH2-terminal nonhelical peptidyl lysine is con-
verted to aldehyde (5). In this report we have concluded that
Hyl-87 in alCB5ald participates as an aldehyde function in the
formation ofthe crosslink OHAlHis. In the fibril packing ofcol-
lagen molecules, as derived from crosslinking studies (8), res-
idues 87-89 in a1CB5 are juxtaposed'to Lys(ald)-17c, which
Fukae and Mechanic (5) propose as the binding site for lysyl
oxidase. The conversion of nonglycosylated Hyl-87 in a1CB5
to an aldehyde supports the proposal that the conversion of
other E-NH2 groups to aldehydes in collagen is due to the jux-
taposition ofthe lysyl oxidase binding site to other sites because
of the specific "quarter-stagger" packing of collagen molecules
in the fibril.
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